Whiterabbit.ai to Present Research on Four Distinct Areas of Focus around Artificial Intelligence and Breast Cancer Screening at the Radiological Society of North America’s 108th Scientific Assembly and Annual Meeting

CHICAGO--(BUSINESS WIRE)--Whiterabbit.ai and partners join radiology leaders from around the world to present new research on four distinct areas of focus: a) AI and consistency in patient care, b) AI-based patient outreach and scheduling program for breast cancer screening that improved compliance across race, age and income demographics, c) using AI to drive revenue and d) identifying and correcting shortcuts that artificially inflate performance in deep learning models at this annual radiological five-day event that focuses on products, innovations and solutions in medical imaging technology.

WHAT:	Four presentations at Radiological Society of North America 2022: Empowering Patients & Partners in Care
WHEN:	Artificial intelligence and consistency in patient care: a large-scale, longitudinal study of breast density assessment
	Speaker: Dr. Susan Holley, Onsite Women’s Health
	Session: Breast Imaging (Breast Density and Supplemental Screening), M6-SSBR04
	Mon., Nov. 28, 1:30 – 2:30 p.m. CT (4th talk of session), E451A
	Post-COVID impact of an AI-driven outreach program on screening mammography compliance in underserved populations
	Speaker: Naomi Zingman-Daniels, Whiterabbit.ai
	Session: Breast Imaging (Factors Influencing Breast Screening – Use and Outcomes), T7-SSBR06
	Tues., Nov. 29, 3 – 4 p.m. CT (4th talk of session), E451B
	Using AI to Drive Revenue
	Speaker: Lindsey Solovey, Whiterabbit.ai
	Session: IT7-AI107
	Tue., Nov. 29, 1:30-1:45 p.m. CT, AI Showcase, South Hall, Level 3
	Problems and shortcuts in deep learning for screening mammography
	Speaker: Trevor Tsue, Whiterabbit.ai
	Session: Breast Imaging (Breast Topics in Screening and Diagnosis), R6-SSBR11
	Thurs., Dec. 1, 1:30-2:30 p.m. CT, (3rd talk of session), E451B
WHERE:	McCormick Place
	2301 S King Drive
	Chicago, IL 60616
CONTACT:	Valerie Enes, [e-mail]

For more information or to view the full program, visit: https://www.rsna.org/annual-meeting/program

About Whiterabbit.ai

Whiterabbit.ai is an AI technology company with a mission to improve lives through earlier, more accurate cancer detection. A growing number of radiologists and healthcare providers are using Whiterabbit's technology to improve patients' experience with breast cancer screening. In addition to ACT, Whiterabbit has developed two other product lines – WRDensity and WRRisk. WRDensity is an FDA-cleared artificial intelligence-driven software that helps radiologists better assess breast density. WRRisk, a clinical decision support software for risk assessment based on well-established breast cancer risk models, assigns a risk rating to a patient and provides vital information to a physician to create a more personalized screening regimen with consistent follow-up and more accurate clinical diagnosis. Whiterabbit is headquartered in Santa Clara, California. For more about Whiterabbit, visit https://whiterabbit.ai/.